We are live on ! Find out more
MOLN

Molecular Partners
MOLN

9 hedge funds and large institutions have $27.7M invested in Molecular Partners in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 4 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.96% less ownership

Funds ownership: 5.32% → 4.36% (-0.96%)

21% less capital invested

Capital invested by funds: $35.1M → $27.7M (-$7.45M)

40% less funds holding

Funds holding: 15 → 9 (-6)

75% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 8

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 4

Holders
9
Holders Change
-6
Holders Change %
-40%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
4
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$8.24M
2
SFM
Sphera Funds Management
Israel
+$1.58M

Top Sellers

Rank Fund Capital Flow
1
MIM
Monashee Investment Management
Massachusetts
-$4.72M
2
BlackRock
BlackRock
New York
-$3.38M
3
HP
Hound Partners
New York
-$2.48M
4
AG
Artal Group
Luxembourg
-$2.05M
5
MWNA
Marshall Wace North America
New York
-$1.97M

MOLN Hedge Fund Activity: Q3 2021 in Review

9 of the 5,727 institutional investors tracked by Wall St. Rank reported a position in Molecular Partners (MOLN) for Q3 2021, worth a combined $27.7M — down 21% from $35.1M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of MOLN and 2 opened new positions — a net loss of 6 holders — while 4 trimmed existing stakes and 0 added.

The largest buyer was BVF Inc, opening a new position worth an estimated $8.24M. The largest seller was Monashee Investment Management, cutting an estimated $4.72M.

  • 9 institutional investors held Molecular Partners (MOLN) as of Q3 2021, down from 15 in Q2 2021.
  • Funds reported $27.7M of Molecular Partners stock for Q3 2021, down 21% quarter-over-quarter.
  • 2 funds opened new Molecular Partners positions in Q3 2021 and 8 closed out, a net change of -6 holders.
  • The largest Molecular Partners buyer in Q3 2021 was BVF Inc, an estimated $8.24M added.
  • The largest Molecular Partners seller in Q3 2021 was Monashee Investment Management, an estimated $4.72M sold.

Based on aggregated 13F filings for Q3 2021.